Filing Details

Accession Number:
0001209191-15-034576
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-04-16 16:16:21
Reporting Period:
2015-04-15
Filing Date:
2015-04-16
Accepted Time:
2015-04-16 16:16:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
57725 Lannett Co Inc LCI Pharmaceutical Preparations (2834) 230787699
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1256670 P Arthur Bedrosian 9000 State Road
Philadelphia PA 19136
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-04-15 5,000 $69.43 621,960 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. 1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Bedrosian on April 17, 2014. The 10b5-1 trading plan will allow Mr. Bedrosian to diversify a portion of his holdings consistent with SEC Rule 10b5-1 and the Company's Insider Trading Policy.